Richard M. Kostrzewa
#164,169
Most Influential Person Now
Richard M. Kostrzewa's AcademicInfluence.com Rankings
Richard M. Kostrzewamedical Degrees
Medical
#3357
World Rank
#3825
Historical Rank
Pharmacology
#417
World Rank
#470
Historical Rank
Download Badge
Medical
Why Is Richard M. Kostrzewa Influential?
(Suggest an Edit or Addition)Richard M. Kostrzewa's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Pharmacological actions of 6-hydroxydopamine. (1974) (785)
- Dopamine receptor supersensitivity (1995) (162)
- Necrostatin‐1 protects against glutamate‐induced glutathione depletion and caspase‐independent cell death in HT‐22 cells (2007) (155)
- Physical Exercise Alleviates ADHD Symptoms: Regional Deficits and Development Trajectory (2012) (121)
- Selective action of 6-hydroxydopa on noradrenergic terminals: mapping of preterminal axons of the brain. (1971) (107)
- Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system. (1992) (94)
- Neurotoxins and neurotoxic species implicated in neurodegeneration (2009) (86)
- Serotonin Neural Adaptations to Ontogenetic Loss of Dopamine Neurons in Rat Brain (1998) (81)
- The role of sulfhydryl groups in oxidative phosphorylation and ion transport by rat liver mitochrondia. (1969) (81)
- Elevated gene expression of glutamate receptors in noradrenergic neurons from the locus coeruleus in major depression. (2014) (79)
- A Comprehensive View of the Epigenetic Landscape Part I: DNA Methylation, Passive and Active DNA Demethylation Pathways and Histone Variants (2014) (77)
- Proposed animal model of attention deficit hyperactivity disorder (1994) (75)
- Influence of Physical Exercise on Neuroimmunological Functioning and Health: Aging and Stress (2011) (74)
- Supersensitized D1 receptors mediate enhanced oral activity after neonatal 6-OHDA (1991) (73)
- Supersensitized oral responses to a serotonin agonist in neonatal 6-OHDA-treated rats (1992) (69)
- Peculiarities of L-DOPA treatment of Parkinson’s disease (2005) (68)
- Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment. (1994) (64)
- Neurotoxin Mechanisms and Processes Relevant to Parkinson’s Disease: An Update (2015) (64)
- Ontogenic homologous supersensitization of quinpirole-induced yawning in rats (1991) (63)
- Alternating extremely low frequency magnetic field increases turnover of dopamine and serotonin in rat frontal cortex (2004) (63)
- Inhibition of connexin43 improves functional recovery after ischemic brain injury in neonatal rats (2015) (61)
- α-MSH and MIF-I effects on catecholamine levels and synthesis in various rat brain areas (1975) (60)
- Low-dose quinpirole ontogenically sensitizes to quinpirole-induced yawning in rats (1993) (58)
- Neuroprotective and neurotoxic roles of levodopa (L-DOPA) in neurodegenerative disorders relating to Parkinson's disease (2002) (57)
- Potentiation of apomorphine action in rats by l-prolyl-l-leucyl-glycine amide (1978) (57)
- The presence of 5-hydroxytryptamine in the eyestalks and brain of the fiddler crab UCA pugilator, its quantitative modification by pharmacological agents, and possible role as a neurotransmitter in controlling the release of red pigment-dispersing hormone* (1974) (54)
- Novel mechanisms and approaches in the study of neurodegeneration and neuroprotection. A review (2009) (53)
- Pharmacological models of ADHD (2007) (51)
- Potentiation of spiperone-induced oral activity in rats after neonatal 6-hydroxydopamine (1991) (49)
- Highly selective neurotoxins : basic and clinical applications (1998) (47)
- Amphetamine-induced enhancement of neostriatal in vivo microdialysate dopamine content in rats, quinpirole-primed as neonates. (2001) (46)
- Investigations on α-MSH and MIF-I effects on cyclic AMP levels in rat brain (1976) (45)
- Dose-related effects of a neonatal 6-OHDA lesion on SKF 38393- and m-chlorophenylpiperazine-induced oral activity responses of rats. (1993) (45)
- Acute effects of 6-hydroxydopa on central monoaminergic neurons. (1973) (44)
- Neonatal 6‐Hydroxydopamine and Adult SKF 38393 Treatments Alter Dopamine D1 Receptor mRNA Levels: Absence of Other Neurochemical Associations with the Enhanced Behavioral Responses of Lesioned Rats (1994) (44)
- Effect of 6-hydroxydopa on catecholamine-containing neurons in brains of newborn rats. (1974) (43)
- Modeling tardive dyskinesia: Predictive 5-HT2C receptor antagonist treatment (2009) (42)
- Sprouting of noradrenergic terminals in rat cerebellum following neonatal treatment with 6-hydroxydopa (1977) (41)
- Neurotoxins and neurotoxicity mechanisms. an overview (2006) (39)
- Impaired ontogeny of striatal dopamine D1 and D2 binding sites after postnatal treatment of rats with SCH-23390 and spiroperidol. (1989) (39)
- Age-dependence of a 6-hydroxydopamine lesion on SKF 38393- and m-chlorophenylpiperazine-induced oral activity responses of rats. (1993) (38)
- Neonatal administration of met-enkephalin facilitates maze performance of adult rats (1980) (37)
- Nicotine blocks quinpirole-induced behavior in rats: psychiatric implications (1999) (37)
- Enhanced oral activity responses to intrastriatal SKF 38393 andm-CPP are attenuated by intrastriatal mianserin in neonatal 6-OHDA-lesioned rats (1995) (37)
- Maternal Lead Exposure Produces Long-Term Enhancement of Dopaminergic Reactivity in Rat Offspring (2007) (37)
- Effects of 6-hydroxydopa on noradrenergic neurons in developing rat brain. (1976) (36)
- Ontogenetic quinpirole treatments produce spatial memory deficits and enhance skilled reaching in adult rats (2002) (36)
- Adulthood nicotine treatment alleviates behavioural impairments in rats neonatally treated with quinpirole: possible roles of acetylcholine function and neurotrophic factor expression (2004) (36)
- Schizophrenia and Substance Abuse Comorbidity: Nicotine Addiction and the Neonatal Quinpirole Model (2012) (34)
- Dopamine receptor supersensitivity: Development, mechanisms, presentation, and clinical applicability (2008) (33)
- The Effects of MSH and MIF on the Brain (1975) (33)
- The effect of 6-hydroxydopa on peripheral adrenergic neurons. (1972) (32)
- Is dopamine-agonist induced yawning behavior a D3 mediated event? (1991) (32)
- Production of prolonged supersensitization of dopamine D2 receptors (1990) (32)
- BMAA and Neurodegenerative Illness (2017) (32)
- Ontogenetic quinpirole treatment induces vertical jumping activity in rats. (1993) (31)
- Serotonin (5-HT) systems mediate dopamine (DA) receptor supersensitivity. (1993) (31)
- The blood-brain barrier for catecholamines — Revisited (2007) (31)
- Focusing on symptoms rather than diagnoses in brain dysfunction: Conscious and nonconscious expression in impulsiveness and decision-making (2008) (30)
- Treatment consideration and manifest complexity in comorbid neuropsychiatric disorders (2007) (30)
- Behavioral and biochemical effects of neonatal treatment of rats with 6-hydroxydopa (1976) (30)
- Affective status in relation to impulsive, motor and motivational symptoms: Personality, development and physical exercise (2008) (30)
- Ontogenic homologous supersensitization of dopamine D1 receptors. (1991) (29)
- Ontogenetic SKF 38393 treatments sensitize dopamine D1 receptors in neonatal 6-OHDA-lesioned rats. (1993) (29)
- Dopaminergic denervation enhances susceptibility to hydroxyl radicals in rat neostriatum (2000) (29)
- Botulinum neurotoxin: Evolution from poison, to research tool - onto medicinal therapeutic and future pharmaceutical panacea (2007) (29)
- Vitamin E supplements fail to protect mice from acute MPTP neurotoxicity. (1991) (28)
- Proposed animal model of severe Parkinson's disease: neonatal 6-hydroxydopamine lesion of dopaminergic innervation of striatum. (2006) (28)
- Handbook of Neurotoxicity (2014) (28)
- Review on apoptosis vs. necrosis of substantia nigrapars compacta in parkinson’s disease (2009) (27)
- Histaminergic Activity in a Rodent Model of Parkinson’s Disease (2009) (27)
- Ontogenetic homologous sensitization to the antinociceptive action of quinpirole in rats. (1991) (27)
- Possible association of increased rat behavioral effects and increased striatal dopamine and norepinephrine levels during the DOPA-potentiation test (1976) (27)
- Persistent spontaneous oral dyskinesias in haloperidol-withdrawn rats neonatally lesioned with 6-hydroxydopamine: absence of an association with the Bmax for [3H]raclopride binding to neostriatal homogenates. (1997) (27)
- Epigenetics and Biomarkers in the Staging of Neuropsychiatric Disorders (2010) (27)
- Staging Neurodegenerative Disorders: Structural, Regional, Biomarker, and Functional Progressions (2011) (26)
- Enhanced quinpirole response in rats lesioned neonatally with 5,7-dihydroxytryptamine (1995) (26)
- DSP-4 prevents dopamine receptor priming by quinpirole (2006) (25)
- Comorbidity of substance abuse with other psychiatric disorders (2007) (24)
- α-MSH and MIF-I effects on serotonin levels and accumulation in various rat brain areas (1975) (24)
- Possible aminergic mediation of MSH release and of the CNS effects of MSH and MIF-I. (1980) (24)
- Genetic variation and shared biological susceptibility underlying comorbidity in neuropsychiatry (2007) (24)
- Effects of L-prolyl-L-leucyl-glycine amide (MIF-I) on dopaminergic neurons (1976) (24)
- Striatal dopamine turnover and MIF-I (1979) (23)
- MIF-I and postsynaptic receptor sites for dopamine (1979) (23)
- Reorganization of noradrenergic neuronal systems following neonatal chemical and surgical injury. (1988) (23)
- Brain sites of movement disorder: Genetic and environmental agents in neurodevelopmental perturbations (2009) (23)
- Ethanol inhibits cadmium accumulation in brains of offspring of pregnant rats that consume cadmium. (1995) (22)
- Impaired striatal dopamine receptor development: differential D-1 regulation in adults. (1988) (22)
- 7-Nitroindazole enhances amphetamine-evoked dopamine release in rat striatum. an in vivo microdialysis and voltammetric study. (2002) (22)
- Prenatal cadmium and ethanol increase amphetamine-evoked dopamine release in rat striatum. (2006) (21)
- Physical Exercise Alleviates Health Defects, Symptoms, and Biomarkers in Schizophrenia Spectrum Disorder (2015) (20)
- Dopamine receptor supersensitivity: An outcome and index of neurotoxicity (2009) (20)
- Effects of a disulfide (Ellman's reagent) and thiols on oxidative phosphorylation and ion transport by rat liver mitochondria. (1969) (20)
- Effect of ketanserin and amphetamine on nigrostriatal neurotransmission and reactive oxygen species in Parkinsonian rats. In vivo microdialysis study. (2006) (20)
- Effects of MPTP and vitamin E treatments on immune function in mice. (1992) (19)
- Perinatal 6-Hydroxydopamine to Produce a Lifelong Model of Severe Parkinson's Disease. (2015) (18)
- Studies on the mechanism of sprouting of noradrenergic terminals in rat and mouse cerebellum after neonatal 6-hydroxydopa (1978) (18)
- Gene-environment interplay in affect and dementia: Emotional modulation of cognitive expression in personal outcomes (2009) (18)
- The catecholaminergic RCSN-3 cell line: A model to study dopamine metabolism (2008) (18)
- Ontogenetic quinpirole treatments fail to prime for D2 agonist-enhancement of locomotor activity in 6-hydroxydopamine-lesioned rats (2009) (18)
- Effects of 6-hydroxydopamine and 6-hydroxydopa on development of behavior (1979) (17)
- Gene-environment interplay in schizopsychotic disorders (2009) (17)
- Loss of nerve cell bodies in caudal locus coeruleus following treatment of neonates with 6-hydroxydopa (1979) (17)
- Neonatal N-(-2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) treatment modifies the vulnerability to phenobarbital- and ethanol-evoked sedative-hypnotic effects in adult rats. (2008) (17)
- Perinatal Treatments with the Dopamine D2-Receptor Agonist Quinpirole Produces Permanent D2-Receptor Supersensitization: a Model of Schizophrenia (2016) (17)
- Tyr-MIF-1 attenuates development of tolerance to spiperone-induced catalepsy in rats (1993) (17)
- Neurotoxins That Affect Central and Peripheral Catecholamine Neurons (1989) (17)
- Enhanced pilocarpine-induced oral activity responses in neonatal 6-OHDA treated rats (1993) (17)
- Effect of prenatal lead exposure on nigrostriatal neurotransmission and hydroxyl radical formation in rat neostriatum: dopaminergic-nitrergic interaction. (2008) (16)
- Staging Perspectives in Neurodevelopmental Aspects of Neuropsychiatry: Agents, Phases and Ages at Expression (2010) (16)
- Opiate-enhanced toxicity and noradrenergic sprouting in rats treated with 6-hydroxydopa. (1981) (16)
- 7-OH-DPAT, unlike quinpirole, does not prime a yawning response in rats (2000) (15)
- Trimetazidine increases [3H]glucose uptake in rat brain. (2006) (15)
- Clinical Staging in the Pathophysiology of Psychotic and Affective Disorders: Facilitation of Prognosis and Treatment (2010) (15)
- Neuroprotective and neurorestorative strategies for neuronal injury (2009) (15)
- MIF-1 attenuates spiroperidol alteration of striatal dopamine D2 receptor ontogeny (1989) (14)
- Neurodevelopmental liabilities in schizophrenia and affective disorders (2002) (14)
- MIF-1 attenuates apomorphine stereotypies in adult rats after neonatal 6-hydroxydopamine. (1989) (14)
- Neonatal co-lesion by DSP-4 and 5,7-DHT produces adulthood behavioral sensitization to dopamine D(2) receptor agonists. (2009) (14)
- Enhanced oral activity response to A77636 in neonatal 6-hydroxydopamine-lesioned rats. (1994) (13)
- Cognitive symptoms facilitatory for diagnoses in neuropsychiatric disorders: Executive functions and locus of control (2008) (13)
- The effects of zinc on the central dopaminergic system of rats prenatally exposed to cadmium (2005) (13)
- Rostral midbrain lesions and copulatory behavior in male rats (1981) (13)
- LOCOMOTOR SENSITIZATION OF DOPAMINE RECEPTORS BY THEIR AGONISTS QUINPIROLEAND SKF-38393, DURING MATURATION AND AGING IN RATS (1998) (13)
- Neurotoxic action of 6-hydroxydopamine on the nigrostriatal dopaminergic pathway in rats sensitized with D-amphetamine. (2005) (13)
- Enhancement of sprouting and putative regeneration of central noradrenergic fibers by morphine (1980) (12)
- Dopamine D2 Receptor Supersensitivity as a Spectrum of Neurotoxicity and Status in Psychiatric Disorders (2018) (12)
- Highly Selective Neurotoxins (1997) (12)
- Ontogenetic noradrenergic lesion alters histaminergic activity in adult rats (2008) (12)
- Histamine H3 receptor agonist- and antagonist-evoked vacuous chewing movements in 6-OHDA-lesioned rats occurs in an absence of change in microdialysate dopamine levels. (2006) (11)
- Antinociceptive Effects of H3 (R-Methylhistamine) and GABAB (Baclofen)-Receptor Ligands in an Orofacial Model of Pain in Rats (2013) (11)
- Perinatal Manganese Exposure and Hydroxyl Radical Formation in Rat Brain (2014) (11)
- Alterations in noradrenergic innervation of the brain following dorsal bundle lesions in neonatal rats (1986) (11)
- Cortical dopaminergic neurotransmission in rats intoxicated with lead during pregnancy. Nitric oxide and hydroxyl radicals formation involvement. (2008) (11)
- Comorbidity implications in brain disease: Neuronal substrates of symptom profiles (2007) (11)
- Gene-environment interplay in alcoholism and other substance abuse disorders: Expressions of heritability and factors influencing vulnerabilities (2009) (11)
- Destruction of cells in the midportion of the locus coeruleus by a dorsal bundle lesion in neonatal rats (1988) (10)
- Lifelong Rodent Model of Tardive Dyskinesia-Persistence After Antipsychotic Drug Withdrawal. (2015) (10)
- Neonatal 6-Hydroxydopamine Lesioning Enhances Quinpirole-Induced Vertical Jumping in Rats that were Quinpirole Primed During Postnatal Ontogeny (2012) (10)
- Noradrenergic fiber sprouting in the cerebellum (1982) (10)
- Transient loss of serum protective activity following short-term stress: a possible biochemical link between stress and atherosclerosis. (1994) (10)
- Persistent oral dyskinesias in haloperidol-withdrawn neonatal 6-hydroxydopamine-lesioned rats. (1994) (10)
- Evolution of Neurotoxins: From Research Modalities to Clinical Realities (2009) (10)
- Gene-environment interplay in neurogenesis and neurodegeneration (2009) (10)
- Destruction of catecholamine-containing neurons by 6-hydroxydopa, an endogenous amine oxidase cofactor (2005) (10)
- Altered histofluorescent pattern of noradrenergic innervation of the cerebellum of the mutant mouse Purkinje cell degeneration (1986) (9)
- Developmental localization of noradrenergic innervation to the rat cerebellum following neonatal 6-hydroxydopa and morphine treatment. (1982) (9)
- Effects of bilateral lesion of the locus coeruleus and of neonatal administration of 6-hydroxydopamine on the concentration of individual proteins in rat brain (1986) (9)
- Development of an opioid-specific action of morphine in modifying recovery of neonatally-damaged noradrenergic fibers in rat brain. (1984) (9)
- Perinatal 6-Hydroxydopamine Modeling of ADHD. (2015) (9)
- Central effects of nafadotride, a dopamine D3 receptor antagonist, in rats. Comparison with haloperidol and clozapine. (2005) (9)
- In vivo and in vitro studies on the neurotoxic potential of 6-hydroxydopamine analogs. (1995) (9)
- Interactive modulation by dopamine and serotonin neurons of receptor sensitivity of the alternate neurochemical system. (1999) (9)
- SENSITIVITY OF CENTRAL DOPAMINE RECEPTORS IN RATS, TO QUINPIROLE AND SKF-38393, ADMINISTERED AT THEIR EARLY STAGES OF ONTOGENICITY, EVALUATED BY LEARN ING AND MEMORIZING A CONDITIONED AVOIDANCE REFLEX (1998) (8)
- Nitric oxide (NO) and central dopamine (DA) D3 receptor reactivity to quinpirole in rats. (1996) (8)
- Neuroteratology and Animal Modeling of Brain Disorders. (2016) (8)
- Attenuation of SCH 23390-induced alteration of striatal dopamine D1 receptor ontogeny by prolyl-leucyl-glycinamide in the rat (1989) (8)
- Prenatal ethanol diminishes reactivity of presumed dopamine D3 receptors in rats. (1995) (8)
- Dopaminergic neuronal systems modulate the central cardiovascular effects of TRH in rats. (1995) (8)
- Exercise and Nutritional Benefits in PD: Rodent Models and Clinical Settings. (2016) (7)
- Neurotoxicological and neuroprotective elements in Parkinson’s disease (2009) (7)
- Neurotoxin Modeling of Brain Disorders—Life-long Outcomes in Behavioral Teratology (2016) (7)
- Effect of Pre- and Postnatal Manganese Exposure on Brain Histamine Content in a Rodent Model of Parkinson’s Disease (2012) (7)
- Neonatal DSP-4 Treatment Modifies Antinociceptive Effects of the CB1 Receptor Agonist Methanandamide in Adult Rats (2012) (7)
- The Inductive Agency of Stress: From Perinatal to Adolescent Induction (2013) (7)
- 6-Hydroxydopa, a Catecholamine Neurotoxin and Endogenous Excitotoxin at Non-NMDA Receptors (1998) (7)
- Ontogenetic Exposure of Rats to Pre- and Post-Natal Manganese Enhances Behavioral Impairments Produced by Perinatal 6-Hydroxydopamine (2010) (7)
- Persistence of long-lasting serotonin depletion by p-chloroamphetamine in rat brain after 6-hydroxydopamine lesioning of dopamine neurons. (1995) (7)
- Effects of neonatal 6-hydroxydopa on behavior in female rats (1980) (7)
- Staging Neurological Disorders: Expressions of Cognitive and Motor Disorder (2010) (6)
- Neonatal DSP-4 treatment impairs 5-HT(1B) receptor reactivity in adult rats. Behavioral and biochemical studies. (2010) (6)
- Schizopsychotic symptom-profiles and biomarkers: Beacons in diagnostic labyrinths (2008) (6)
- Selective neurotoxins, chemical tools to probe the mind: The first Thirty years and beyond (1999) (6)
- Effect of Low Frequency Electromagnetic Fields on ( 3 H)Glucose Uptake in Rat Tissues (2007) (6)
- Synthetic Cathinones: Neurotoxic Health Hazards and Potential for Abuse (2018) (6)
- Quinpirole-induced yawning behaviour in rats neonatally pretreated with 6-hydroxydopamine (6-OHDA) and 5,7-dihydroxytryptamine (5,7-DHT) (1997) (6)
- MIF-1 fails to modify agonist-induced oral activity in neonatal 6-OHDA-treated rats (1993) (6)
- Effects of melanocyte stimulating hormone melanocyte and stimulating release inhibiting factor on rat brain serotonin levels and formation rates (1974) (5)
- Cadmium modulates reactivity of central dopamine receptors in rats prenatally exposed to ethanol (1995) (5)
- Exposure of Pregnant Rats to Manganese: Effect on Levels, Turnover and Release of Biogenic Amines in Brains of Their Offspring (2002) (5)
- Physical Exercise Alleviates ADHD Symptoms: Regional Deficits and Development Trajectory (2011) (4)
- Ontogenetic Serotoninergic Lesioning Alters Histaminergic Activity in Rats in Adulthood (2011) (4)
- Effect of aluminium exposure on central serotonine and muscarine receptors reactivity in rats (1997) (4)
- Neurodevelopmental liabilities of substance abuse (2002) (4)
- Nitric oxide modulates the amphetamine effect on [3H]glucose uptake in the brain of rats prenatally exposed to lead. (2007) (4)
- Histaminergic activity in adult rats neonatally lesioned with neurotoxins: DSP-4, 5,7-DHT and 6-OHDA (rodent model of Parkinson's disease) (2009) (4)
- Nitro-l-arginine attenuates SKF 38393-induced oral activity in neonatal 6-hydroxydopamine-lesioned rats. (1997) (3)
- Ontogenetic manganese exposure with perinatal 6-OHDA lesioning alters behavioral responses of rats to dopamine D₁ and D2 agonist treatments. (2014) (3)
- REGENERATIVE SPROUTING OF NORADRENERGIC TERMINALS IN THE CEREBELLUM (1979) (3)
- Ontogenetic Quinpirole Treatment Produces Spatial Memory Deficits and Reaching Accuracy Enhancement in Rats (2001) (3)
- [Molecular mechanisms of levodopa action in animal models of Parkinson's disease]. (2006) (3)
- p-Chloroamphetamine-Enhanced Neostriatal Dopamine Exocytosis in Rats Neonatally Co-lesioned with 6-OHDA and 5,7-DHT: Relevance to Parkinson’s Disease (2020) (3)
- Effect of Pre- and Postnatal Exposure to Zinc on ( 3 H)glucose Uptake in the Brain and Peripheral Tissues of Adult Rats (2006) (3)
- Perinatal Lesioning and Lifelong Effects of the Noradrenergic Neurotoxin 6-Hydroxydopa. (2016) (2)
- Comparison DOPAC release in the striatum and some behavioral effects of quinpirole and 7-OH-DPAT, the dopamine D2/D3 receptors agonists in rats (1999) (2)
- Neurotoxicity and substance abuse: Further fuel for regulatory dilemma (2009) (2)
- Effects of sarizotan in animal models of ADHD: challenging pharmacokinetic–pharmacodynamic relationships (2015) (2)
- ALTERED SENSITIVITY OF RECOGNITION SITES FOR A NEUROTRANSMITTER IN THE ABSENCE OF CHANGES IN RECEPTOR BINDING PARAMETERS: CO-SENSITIZATION OF AN ALTERNATE SYSTEM (1993) (2)
- The Neuronal Environment (2002) (2)
- P3.054 Effect of prenatal manganese intoxication on dopaminergic neurotranssmision in the brain of rats lesioned as neonates with 6-hydroxydopamine (2009) (2)
- Necroptosis, a Potential Therapeutic Target for Neurological Disorders (2014) (2)
- A Comprehensive View of the Epigenetic Landscape Part I: DNA Methylation, Passive and Active DNA Demethylation Pathways and Histone Variants (2014) (2)
- Personality and Brain Disorders: Associations and Interventions (2019) (1)
- Behavioral and biochemical effects of new central dopamine D3 ((U-99194A) and D4 (U- 10 1958) receptor antagonists in rats (2001) (1)
- Insidious dopamine: provocateur or protective agent in Parkinson's disease? (2001) (1)
- α-methyl-6-aminodopamine: Depletion of catecholamines in mouse brain and peripheral tissues (1980) (1)
- Minimal brain dysfunction: dopamine depletion? (1976) (1)
- Thioperamide effect on (3H)glucose uptake in the brain of adult rats neonatally lesioned with 5,7-dihydroxytryptamine (2009) (1)
- Dopamine and 5-HT receptor sensitivity does not correlate with neostriatal dopamine or 5-HT content. (1996) (1)
- Effects of neonatal 6-hydroxydopa treatment on monamine content of rat brain and peripheral tissues. (1975) (1)
- Tardive Dyskinesia: Outcome of Antipsychotic Treatment and Brain Damage? (2021) (1)
- Survey of Selective Neurotoxins (2014) (1)
- Neonatal 6-hydroxydopamine lesioning of rats and dopaminergic neurotoxicity: proposed animal model of Parkinson’s disease (2022) (1)
- II Neurotoxicity Society Meeting. Mechanisms for neurodegenerative disorders. (2005) (1)
- Developmental Lead Exposure Impairs Anxiolytic-Like Effects of Diazepam and 8-OH-DPAT in Male Wistar Rats (2008) (1)
- Histamine content in rat brains with rodent model of Parkinson’s disease exposured to manganese during pre- and postnatal development (2011) (0)
- INDUCTION OF GROOMING BEHAVIOR IN MALE RATS BY M-CHLORPHENYLPIPERAZINE, A CENTRAL 5-HYDROXYTRYPTAMINE RECEPTOR AGONIST (1998) (0)
- Survey of Selective Monoaminergic Neurotoxins Targeting Dopaminergic, Noradrenergic, and Serotoninergic Neurons (2022) (0)
- Neurotoxin Mechanisms and Processes Relevant to Parkinson’s Disease: An Update (2015) (0)
- P17 HISTAMINE H3 AGONIST- AND HISTAMINE H3 ANTAGONIST-EVOKED VACUOUS CHEWING OCCURS IN THE ABSENCE OF CHANGE IN MICRODIALYSATE DOPAMINE LEVELS (2006) (0)
- IV Neurotoxicity Society Meeting: Neurochemical Mechanisms of Neurodegenerative Disorders (2010) (0)
- 6-Hydroxydopa: A Precursor-Neurotoxin with Relative Selectivity for Noradrenergic Neurons (2021) (0)
- P 14 . 4 Comparison of the influence of selected polysiloxane derivatives on the growth of Chlorella vulgaris algal cultures (2007) (0)
- 215. Apparent Sprouting of Noradrenergic Fibers in Association with Hypoplasia of Cat Cerebellum Following a Panleukopenia Viral Infection in utero. (1982) (0)
- The Adenosinergic System (2015) (0)
- 1007 – AGE-RELATED ALTERATIONS IN NOREPINEPHRINE CONTENT BY 6-HYDROXYDOPA IN REGIONS OF RAT BRAIN RECEIVING PROJECTIONS FROM THE LOCUS COERULEUS (1977) (0)
- Neurotoxicity meeting - mechanisms for neurodegenerative disorders. 16-18 March 2001, Pucon, Chile. (2001) (0)
- p-Chloroamphetamine-Enhanced Neostriatal Dopamine Exocytosis in Rats Neonatally Co-lesioned with 6-OHDA and 5,7-DHT: Relevance to Parkinson’s Disease (2020) (0)
- Investigations on alpha-MSH and MIF-1 effects on cyclic AMP levels in rat brain. (1976) (0)
- Nitric oxide (NO) and central dopamine (DA) receptors reactivity in rats (1995) (0)
- Sensitization to dopamine (DA) and 5-hydroxy-tryptamine (5-HT) agonists is not correlated with alterations in DA and 5-HT contents of neostriatum after neonatal intrastriatal 6-hydroxydopamine injections in rats (1995) (0)
- Effect of the central dopamine and serotonin receptor agonist on biogenic amines release in rats brain with experimental model of attention deficit hyperactivity disorder (ADHD) in vivo brain microdialysis study (2001) (0)
- Effect of Pre- and Postnatal Manganese Exposure on Brain Histamine Content in a Rodent Model of Parkinson’s Disease (2011) (0)
- P3.144 Acute L-DOPA effect on hydroxyl radical- and DOPAC-levels in striatal microdialysates of Parkinsonian rats (2009) (0)
- 307 – STIMULATION OF REGENERATIVE SPROUTING IN THE CENTRAL NERVOUS SYSTEM BY NERVE GROWTH FACTOR (1978) (0)
- P3.144 Acute L-DOPA effect on hydroxyl radical- and DOPAC-levels in striatal microdialysates of Parkinsonian rats (2009) (0)
- Monoaminergic system interactions in neurotoxicity (2015) (0)
- Perinatal Manganese Exposure and Hydroxyl Radical Formation in Rat Brain (2014) (0)
- alpha-Methyl-6-aminodopamine: depletion of catecholamines in mouse brain and peripheral tissues. (1980) (0)
- Insights on neurochemical mechanisms of hyperactivity and potentially new therapeutic strategies (1999) (0)
- In vivo voltammetric determination of the enhanced spiperone - induced release of dopamine (DA) and dihydroxyphenylacetic acid (DOPAC) in neostriatum of rats with supersensitized DA D2-receptors (1995) (0)
- Alpha-MSH and MIF-2 effects on serotonin levels and accumulation in various rat brain areas. (1975) (0)
- Perinatal Treatments with the Dopamine D2-Receptor Agonist Quinpirole Produces Permanent D2-Receptor Supersensitization: a Model of Schizophrenia (2015) (0)
- Staging Neuropsychiatric Disorders (2012) (0)
- HISTAMINEH 3 RECEPTORLIGANDS MODULATEL-DOPA-DERIVEDEXTRACELLULARDOPAMINE IN DOPAMINE-DENERVATEDRATSTRIATUM (2006) (0)
- Neuropharmacological Aspects of Hypothalamic Peptides and α-MSH (1978) (0)
- Neonatal DSP-4 Treatment Modifies Antinociceptive Effects of the CB1 Receptor Agonist Methanandamide in Adult Rats (2012) (0)
- Antinociceptive Effects of H3 (R-Methylhistamine) and GABAB (Baclofen)-Receptor Ligands in an Orofacial Model of Pain in Rats (2013) (0)
- Targeting Necroptosis as Therapeutic Potential in Central Nervous System Diseases (2021) (0)
- 198 – CHANGES IN RAT BRAIN SEROTONIN AND CATECHOLAMINES AFTER α-MSH OR MIF-I TREATMENT (1977) (0)
- Novel roles of amino acids and analogues in neurodegenerative disorders – Introduction (2002) (0)
- Effect of the aminoacid L-Arginine and its analog Nitro-L-Aginine methyl ester HCl (L-Name) on central dopamine (DA) receptor reactivity (1997) (0)
- D-Ala2,F5Phe4-dynorphin amide, an opiate with analgesic and toxic properties. (1992) (0)
- Neonatal DSP-4 Treatment Modifies Antinociceptive Effects of the CB1-Receptor Agonist Methanandamide in Adult Rats (2012) (0)
- Physical Exercise Alleviates Health Defects, Symptoms, and Biomarkers in Schizophrenia Spectrum Disorder (2015) (0)
- Neonatal 6-Hydroxydopamine Lesioning Enhances Quinpirole-Induced Vertical Jumping in Rats that were Quinpirole Primed During Postnatal Ontogeny (2011) (0)
- Central noradrenergic system lesion by DSP-4 prevent qninpirole ontogenically sensitization to quinpirole-induced yawning in rats (2005) (0)
- The changing face of neurotoxins (2013) (0)
- Effect of L-arginine and nitro-L-arginine methyl ester (L-NAME) on amphetamine and apomorphine induced stereotyped behavior and Dopac release in the striatum of rats (1999) (0)
- P16 HISTAMINE H3 RECEPTOR LIGANDS MODULATE L-DOPA-DERIVED EXTRACELLULAR DOPAMINE IN DOPAMINE-DENERVATED RAT STRIATUM (2006) (0)
- Program and abstracts of the First Int’l Meeting: Mechanisms for Neurodegenerative Disorders—Alzheimer, Amyotropic Lateral Sclerosis (ALS) and Parkinson’s Disease (2009) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Richard M. Kostrzewa?
Richard M. Kostrzewa is affiliated with the following schools:
